Efficacy results (N = 25)
| Outcome . | No. of patients . | % of patients . |
|---|---|---|
| ORR (CR + CRp) | 11 | 44 |
| CR | 7 | 28 |
| CRp | 4 | 16 |
| PR | 3 | 12 |
| Any response (CR + CRp + PR) | 14 | 56 |
| OS, wk | ||
| Median | 10.7 | — |
| Range | 1-113.1+ | — |
| EFS | ||
| Median, wk | 10.7 | — |
| Range, wk | 1-113.1+ | — |
| 4 months, % | 44 | — |
| Duration of remission, wk (n = 11) | ||
| Censored at last follow-up | ||
| Median | 67.3 | — |
| Range | 2.9-109.6+ | — |
| Censored at alternative therapy | ||
| Median | NE | — |
| Range | 0.1+-10.9+ | — |
| Outcome . | No. of patients . | % of patients . |
|---|---|---|
| ORR (CR + CRp) | 11 | 44 |
| CR | 7 | 28 |
| CRp | 4 | 16 |
| PR | 3 | 12 |
| Any response (CR + CRp + PR) | 14 | 56 |
| OS, wk | ||
| Median | 10.7 | — |
| Range | 1-113.1+ | — |
| EFS | ||
| Median, wk | 10.7 | — |
| Range, wk | 1-113.1+ | — |
| 4 months, % | 44 | — |
| Duration of remission, wk (n = 11) | ||
| Censored at last follow-up | ||
| Median | 67.3 | — |
| Range | 2.9-109.6+ | — |
| Censored at alternative therapy | ||
| Median | NE | — |
| Range | 0.1+-10.9+ | — |
PR indicates partial remission; —, not applicable; and NE, not estimable.